Europap Tezol (Turkey) Performance
TEZOL Stock | 14.49 0.50 3.34% |
The firm shows a Beta (market volatility) of 0.0938, which means not very significant fluctuations relative to the market. As returns on the market increase, Europap Tezol's returns are expected to increase less than the market. However, during the bear market, the loss of holding Europap Tezol is expected to be smaller as well. At this point, Europap Tezol Kagit has a negative expected return of -0.22%. Please make sure to confirm Europap Tezol's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if Europap Tezol Kagit performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Europap Tezol Kagit has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
Begin Period Cash Flow | 154.2 M |
Europap |
Europap Tezol Relative Risk vs. Return Landscape
If you would invest 1,698 in Europap Tezol Kagit on September 25, 2024 and sell it today you would lose (249.00) from holding Europap Tezol Kagit or give up 14.66% of portfolio value over 90 days. Europap Tezol Kagit is generating negative expected returns and assumes 2.4462% volatility on return distribution over the 90 days horizon. Simply put, 21% of stocks are less volatile than Europap, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Europap Tezol Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Europap Tezol's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Europap Tezol Kagit, and traders can use it to determine the average amount a Europap Tezol's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0909
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | TEZOL |
Estimated Market Risk
2.45 actual daily | 21 79% of assets are more volatile |
Expected Return
-0.22 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Europap Tezol is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Europap Tezol by adding Europap Tezol to a well-diversified portfolio.
Europap Tezol Fundamentals Growth
Europap Stock prices reflect investors' perceptions of the future prospects and financial health of Europap Tezol, and Europap Tezol fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Europap Stock performance.
Revenue | 878.15 M | |||
EBITDA | 297.13 M | |||
Total Debt | 208.46 M | |||
Book Value Per Share | 4.94 X | |||
Cash Flow From Operations | 265.36 M | |||
Total Asset | 1.25 B | |||
About Europap Tezol Performance
By evaluating Europap Tezol's fundamental ratios, stakeholders can gain valuable insights into Europap Tezol's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Europap Tezol has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Europap Tezol has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Europap Tezol Kagit performance evaluation
Checking the ongoing alerts about Europap Tezol for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Europap Tezol Kagit help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Europap Tezol Kagit generated a negative expected return over the last 90 days | |
About 71.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Europap Tezol's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Europap Tezol's stock is overvalued or undervalued compared to its peers.
- Examining Europap Tezol's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Europap Tezol's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Europap Tezol's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Europap Tezol's stock. These opinions can provide insight into Europap Tezol's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Europap Stock analysis
When running Europap Tezol's price analysis, check to measure Europap Tezol's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Europap Tezol is operating at the current time. Most of Europap Tezol's value examination focuses on studying past and present price action to predict the probability of Europap Tezol's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Europap Tezol's price. Additionally, you may evaluate how the addition of Europap Tezol to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Correlations Find global opportunities by holding instruments from different markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |